Surgam Léčiva Σλοβακία - Σλοβακικά - ŠÚKL (Štátny ústav pre kontrolu liečiv)

surgam léčiva

sanofi-aventis slovakia s.r.o., slovensko - kyselina tiaprofénová - 29 - antirheumatica, antiphlogistica, antiuratica

Sugammadex Fresenius Kabi Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulárna blokáda - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Mylan Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - zvrat neuromuskulárnej blokády indukovanej rokurónom alebo vekuróniom. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Bridion Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

bridion

merck sharp & dohme b.v. - sugammadex - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - zvrat neuromuskulárnej blokády indukovanej rokurónom alebo vekuróniom. pre peadiatric počet obyvateľov: sugammadex je iba doporučené na bežné storno rocuronium vyvolaných blokáda u detí a dospievajúcich.